BRCA1/2 mutations are found in approximately 14% of non-small cell lung cancer (NSCLC) patients and about 12% of small cell lung cancer (SCLC) patients (Ji et al., 2020). The gene discussed is BRCA1; the disease is non-small cell lung carcinoma.